产品名称：Novus/INSTA-Blot Colon Tissue OncoPair/NBP2-30129

产品编号：NBP2-30129

市场价：¥7980.00

场地：美国(厂家直采)

产品分类：蛋白类>重组蛋白>其它重组蛋白>

联系QQ：1570468124

电话号码：4000-520-616

邮箱： info@ebiomall.com

美元价：$399.00

品牌： Novus

公司：Novus Biologicals

公司分类：

商品介绍

Description

Tissue

Lane	Tissue Type	Cat. No.	Grade	Stage	Sex	Age	Diagnosis
MWM
2	Colon	NBP2-28142	1	I	M	75	Adenocarcinoma
3	Colon	NBP2-28140					Normal adjacent
4	Colon	NBP2-28146	1	I	M	25	Adenocarcinoma
5	Colon	NBP2-28144					Normal adjacent
6	Colon	NBP2-28184	1	II	M	77	Adenocarcinoma
7	Colon	NBP2-28182					Normal adjacent
8	Colon	NBP2-28263	1	II	F	38	Adenocarcinoma
9	Colon	NBP2-28261					Normal adjacent
10	Colon	NBP2-28273	1	II	F	46	Adenocarcinoma
11	Colon	NBP2-28271					Normal adjacent
12	Colon	NBP2-28306.	1	IIIA	F	66	Adenocarcinoma
13	Colon	NBP2-28304					Normal adjacent
14	Colon	NBP2-28311	1	IIIA	F	43	Adenocarcinoma
15	Colon	NBP2-28309					Normal adjacent

Background

The development of biomarkers has enormous potential for revolutionizing the diagnosis and treatment of disease. Western blot analysis is an integral technique for biomarker profiling.While key for biomarker discovery, the existing body of western blot data has primarily been defined from studies of tumor, immortal, and primary cells growing in vitro. Collectively, results obtained over de...cades have been integral to the dogma that up- and down-regulation of proteins can be leveraged as biomarkers of normal development, homeostasis, and disease. However, data from human tissue-derived products is key for generating biomarker validation data and progressing the most promising biomarker targets towards the clinic. The OncoPair INSTA-Blot™ product line addresses the increasing demand for the inclusion of human tissue-derived products in biomarker profiling.The OncoPair INSTA-Blot™ is a ready-to-use PVDF western blot membrane containing denatured protein lysates manufactured from Novus"s extensive Human Clinical Tissue Lysate collection. Each blot contains 14 lanes of alternating tumor (T) and matched normal adjacent (NA) tissue lysates from 7 patient donors. Incorporating both T and NA on the blot enables protein expression analysis of the tumor and microenvironment. The tumor microenvironment is increasingly being recognized as a major factor in influencing malignant progression and metastatic potential. Cancer is a heterogeneous disease and the presence of multiple donors on a single blot enables rapid screening of protein expression variability between T/NA from different individuals and at different disease stages. Clinical diagnosis and histopathology reports from board-certified pathologists are available for every patient sample. OncoPair INSTA-Blots™ are available for a wide range of tumor types and stages. The product line is manufactured from donor patient tissue obtained from established hospital-based collection sites around the world. Tissues are collected under strict bioethical standards using IRB and HIPAA approved protocols. These protocols ensure patient confidentiality, safety, and informed consent.Tissues are flash frozen at collection sites within minutes of removal, maintained in liquid nitrogen and processed into lysates using protocols optimized for extracting proteins from tissues. Lysates are denatured for OncoPair INSTA-Blot™ production; native lysates are available for follow up proteomic studies. OncoPair INSTA-Blots™ and lysates are also useful in conjunction with the Cell Line and Normal Tissue INSTA-Blots™ and lysates for comprehensive antibody validation and to profile antibody reactivity and protein expression patterns across species and between tissues and cells lines.

PreparationMethod

Tissue specimens were homogenized in modified RIPA buffer to obtain the soluble proteins and centrifuged to clarify. Sample buffer was added to the soluble fraction and approximately 14 ug/lane of protein was run and then transfered to PVDF membrane. -Soluble fraction extraction buffer (extract 1): PBS at pH 7.4, 1 ug/ml Aprotinin, 1 mM NaF -Modified RIPA buffer: 1 mM EDTA, 1 ug/ml Pepstatin-A, 0.1% SDS, 0.25% Na deoxycholate, 1 ug/ml Leupeptin, 1 mM PMSF, 1 mM Na3VO4 -5X Sample buffer: 50 ml glycerol, 15 g SDS, 3.819 g Tris, pH 6.8, 25 ml 2-ME, 100 mg bromophenol blue, final volume of 100 ml with DI H2O

Application Notes

Use in Western blot reported in scientific literature (PMID 25985210)

Publications

ReadPublications using NBP2-30129 in the following applications:

WB
3 publications

品牌介绍

About

Novus Biologicals

Accelerate Scientific Discovery by Developing Unique Products

The mission of Novus Biologicals, LLC is to accelerate scientific discovery by developing and marketing unique products for the lifesciences. Novus Biologicals is also organized to provide the biological research community with a mechanism for commercializing unique biological materials. We also focus on continually monitoring scientific trends and supply materials to serve these trends. By making these products widely available to institutional and commercial researchers, Novus Biologicals plays an important role in furthering biological research.

All of Novus Biologicals products are supplied with detailed technical information and ongoing support. By serving both niche and emerging markets, Novus Biologicals has built solid partnerships with our customers. Contact us for more information.

Novus Biologcials is part of the Bio-Techne family which includes:

R&D Systems
ProteinSimple
Advanced Cell Diagnostics
Tocris
Biospacific
Cliniqa
Boston Biochem
Bionostics
RNA Medical